Alisha Holloway

Cannabis genetics company Phylos, in partnership with People Science, conducted an Institutional Review Board-approved, double-blind clinical study on the effects of rare cannabinoid tetrahydrocannabivarin (THCV). According to the research, Natural Natural THCV developed by Phylos resulted in...